PARSIPPANY, NJ, Oct 03, 2011 (MARKETWIRE via COMTEX) -- The Medicines Company (MDCO) announced today launch of a new twelve hour formulation for Cleviprex(R) (clevidipine) Injectable Emulsion, which ...
Credit: Getty Images. HTX-019 is a proprietary IV injectable emulsion formulation designed to directly deliver aprepitant, a substance P/NK1 receptor antagonist, as a 30-second IV injection. A New ...
APONVIE, an aprepitant product, highlighted as the only FDA-approved IV formulation Neurokinin-1 (“NK-1”) antagonist indicated for the prevention of PONV in adults, with a long half-life and quicker ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (“ANDA”) approval from ...
The U.S. Food and Drug Administration has expanded the approval of Cinvanti injectable emulsion to include a two-minute intravenous use for the prevention of acute and delayed chemotherapy-induced ...
Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company, announces the positive safety review by the independent Data and Safety Monitoring Board for its Casppian phase 3 registration ...
New formulations provide up to 60% more protein (amino acid) than current Clinimix formulations while delivering less dextrose1 Baxter provides innovative and accessible products and services designed ...
An injectable emulsion containing two omega-3 fatty acids found in fish oil markedly reduced brain damage in newborn rodents after a disruption in the flow of oxygen to the brain near birth, a study ...
The Medicines Company announced launch of a new twelve hour formulation for Cleviprex (clevidipine) injectable emulsion, which was approved by the US Food and Drug Administration (US FDA) in June 2011 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback